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Abstract 
Semen cryopreservation is a very important technique for assisted reproduction; 
however, the cryopreservation process is harmful because it results in a reduction in 
sperm motility and viability, and leads to premature signals of capacitation, resulting in 
lesser than desirable fertility rates after artificial insemination. A fraction of seminal 
plasma, enriched in proteins that contain type II fibronectin domains (FNII) can reverse 
molecular indicators of cryo-capacitation. The beneficial effects of these proteins, 
however, depend on the relative abundance in seminal plasma. To create a safe additive 
for improving frozen sperm functionality, in the present study there was cloning and 
expression of a recombinant peptide containing four FNII domains (named TrxA-FNIIx4-
His6) and evaluation of its effect after addition to frozen/thawed ram sperm. The cDNA 
for this protein was expressed in E. coli and after denaturation and re-naturalization of 
the protein, toxicity and binding capacity were assessed. By fluorescent labelling 
assessment, there was binding of the protein to the thawed sperm. At the two doses 
used (0.15 and 0.3 µM), TrxA-FNIIx4-His6 had the capacity to reverse the molecular 
indicators of cryo-capacitation as indicated by the reduction on phosphorylated 
substrates of PKA. Furthermore, the supplementation with this protein resulted in a 
normal capacitation process as evidenced by the increase in the in vitro fertilization rate 
when the greatest concentration of the protein was evaluated (73.25 ± 2.95; 40.13 ± 
11.82 for 0.3 µM and control, respectively). There was no effect of protein 
supplementation on sperm objective motility compared to untreated sperm. In 
conclusion, the use of TrxA-FNIIx4-His6 is a promising biotechnological approach for 
cryopreserving ram sperm and maintaining sperm viability. 
 
Keywords: Recombinant peptide; Fibronectin (FNII) domains; Cryopreservation; Ram; 
Seminal plasma 
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1. Introduction 
The cryopreservation process, involving cooling, freezing and thawing, induces 
serious detrimental changes in sperm function (Watson 1981). Sperm sensitivity to this 
process is species-specific due to its shape and size and the biophysical-biochemical 
properties of plasmatic membranes that differ between species and males (Curry, 2007). 
Ram sperm are more sensitive to structural damage than sperm from bulls, rabbits or 
men (White, 1993). Cryopreservation reduces viability, motility, and mitochondrial 
activity, as well as imposing the process induces chromatin damage, increases reactive 
oxygen species, activates apoptosis mechanisms (Said et al., 2010) and perhaps most 
importantly, is the premature induction of a capacitation-like process known as cryo-
capacitation (Bailey et al., 2003; Reddy et al., 2010). Cryo-capacitation is characterized 
by a membrane reorganization with loss of polyunsaturated fatty acids and cholesterol 
(Maldjian et al., 2005; Chakrabarty et al., 2007) with further development of molecular 
hallmarks of capacitation such as an intracellular calcium increase (Hagiwara et al., 
2009; Oldenhof et al., 2010) and protein phosphorylation (Kumar and Atreja, 2012; Singh 
et al., 2012). All these alterations might reduce longevity of the cryopreserved 
spermatozoa within the female reproductive tract, decreasing the likelihood of typical 
oviductal-sperm interactions or affecting the fertilization process. 
Incubation of frozen/thawed ram sperm with seminal plasma (SP) resulted in 
improvements in sperm variables including motility, viability (Ollero et al., 1997; 
Domínguez-Rebolledo et al., 2007; Domínguez et al., 2008) and resulting fertilization 
rate when SP was added to the incubation media (Maxwell et al., 2007). The beneficial 
effect of SP on sperm has been attributed to its protein components, because seminal 
plasma proteins (SPP) function to increase sperm resistance against cold-shock (Barrios 
et al., 2000; Pérez-Pé et al., 2001; Colás et al., 2009). The SPP support survival of ram 
spermatozoa functioning not only at the plasma membrane  but also by inhibiting cryo-
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capacitation (Desnoyers and Manjunath, 1992; Barrios et al., 2005) and apoptosis-
like process changes (Mendoza et al., 2013). Bernardini et al. (2011) reported that a 
fraction of SPP with affinitive binding properties for the sperm membrane, termed 
interacting SP proteins (iSPP), had the capacity to reverse ultrastructural cell damage 
and improve motility of frozen/thawed ram sperm. Furthermore, the addition of iSPP to 
frozen/thawed sperm reversed the development of molecular indicators of cryo-
capacitation such as tyrosine protein phosphorylation (Ledesma et al., 2016). The iSPP 
fraction is enriched in two proteins, RSVP14 and RSVP20, that belong to the BSP protein 
family (Binder of Sperm Proteins), for which the primary characteristic is the presence of 
two fibronectin type II (FNII) tandem domains. The FNII domains interact with the choline-
phospholipids of the plasma membrane of sperm (Plante et al., 2016) and it has been 
proposed that the phospholipid-domain interaction would prevent the free movement of 
phospholipids in the membrane, stabilizing the membrane structure (non-capacitated 
stage) (Manjunath and Therien, 2002) until a signal of physiological induction occurs. 
Because RSVP14 and RSVP20 concentration in SP varies according to the reproductive 
season (Pérez-Pé et al., 2001; Domínguez et al., 2008), there has been a focus in many 
studies on the development of protocols to produce these proteins in vitro. Given the 
binding properties reported for the FNII domain (Therien et al., 2005), it was 
hypothesized that a recombinant peptide with FNII tandem repeats would mimic the 
beneficial effects of SP on frozen-thawed ram sperm.  
The aim of the present study, therefore, was cloning and over-expression of a 
recombinant fragment of the epididymal sperm binding protein 1 (ELSPBP1) gene from 
Bos taurus cattle with the resulting protein being composed of four fibronectin type II 
domains in the heterologous system of Escherichia coli (E. coli). Furthermore, to gain 
insight into the physiological effect of this recombinant protein, motility, capacitation 
status and fertilizing potential were evaluated in frozen-thawed ram sperm. 
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2. Materials and methods 
 
 
2.1. Bovine epididymis library construction 
Epididymis RNA was obtained from Zyagen (BR-402; San Diego, US). Total 
RNA (100 µg) was examined on an Agilent Bioanalyzer 2100 system using the RNA 
6000 Nano kit (Agilent Technologies, Santa Clara, CA, USA; Figure 1A). 
Subsequently, mRNA was purified from those samples using an Oligotex kit 
(QIAGEN, USA) and the concentration and quality were determined by RNA 6000 
Nano chips were processed using an Agilent Bioanalyzer 2100 system (Agilent 
Technologies) resulting in 6 µg mRNA (figure 1B). A cDNA Library was constructed 
in the pDONR222 vector (Gateway compatible) using the CloneMiner kit (Invitrogen, 
Carlsbad, CA, USA) following the manufacturer’s non-radiolabeling protocol with 
some modifications. After attB1 adapter ligation, the cDNA content was assessed 
and then fractionated using column chromatography. Each fraction (1 µL) was 
evaluated using capillary electrophoresis (Bioanalyzer 2100) with which the DNA 
7500 chip kit was compared with the internal standard (figure 1C). Fractions were 
selected and pooled based on the criteria suggested by the manufacturer, the 
pooled samples were ethanol precipitated, suspended in TE buffer and 
concentration of cDNA was calculated on a DNA 7500 chip. All subsequent methods 
of the CloneMiner cDNA library construction kit protocol were performed according 
to the manufacturer´s instructions. 
Serial dilutions of the library were plated on LB plates containing 50 ug/mL 
kanamycin (LBkan) and incubated overnight at 37 °C to determine the libraries titer. 
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A minimum of 24 kanamycin-resistant clones were randomly selected and cultured 
using LBkan. Plasmid from harvested colonies were isolated using the QIAprep Spin 
Miniprep Kit (QIAGEN) and digested with BsrGI to determine the average size of the 
inserts and percentage of recombinants (Figure 1D). The amplification of an aliquot 
of the primary cDNA libraries was performed a semi-solid amplification protocol 
provided by Invitrogen. The resulting library had a primary titer of 6.5 x 106 cfu/mL, 
a secondary 9.75 x 1014 cfu/mL and average insert size of 1.21 Kbp with 88% 
recombinants. 
 
2.2. Recombinant protein in E. coli and purification 
The EPIDIDYMAL SPERM BINDING PROTEIN 1 (ELSPBP1) contains four 
characteristic fibronectin type II domains (FNII) in tandem. The sequences encoding 
these FNII domains (FNII x4 cDNA) (ELSPBP1) were amplified from a bovine epididymal 
cDNA library. The restriction sites KpnI and Xho were included in the forward (Fw: 5'- 
131CGGGGTACCTCATGCATCTTTC-3') and reverse (Rv: 5' 
CCGCTCGAGGCAGTACAC-3')   primers,   respectively.   The PCR reactions were 
prepared in a reaction mixture (20 μL) containing: Taq 1x buffer, 200 μM dNTPs, 1.5 mM 
Cl2Mg, 1 μM primers Fw and Rv, 0.5U Taq DNA polymerase (0.5 U/μL) and 5 μL of 
template (bovine epididymal library dilution containing 9.75 x 1010 cfu/mL). The PCR 
cycling conditions consisted of 2 min at 94 °C, 35 cycles of 1 min at 94 °C, a step of 
hybridization at 53 °C for 1 min, an elongation step at 72 °C for 1 min and at the end 72 
°C for 7 min. A negative control cycle without inclusion of the template was also 
performed. A positive control was included consisting in the amplification of the β-actin 
cDNA by 1 μM primers: β ACT-Fw 1405'-TTCCGATGCCCTGAGGCTCTTTTC-3'and β 
ACT-Rev 5'-CTTGCTGATCCACATCTGCTGGAA-3'. The amplified fragments (597 bp) 
were visualized in 1% (wt/vol) agarose gel, excised and purified using the Puro I Clean 
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Up kit (Biological Products). 
The cDNA encoding the four FNII domains of ELSPBP1 (FNII x4 cDNA) was sub-
cloned in the expression vector pET-32 Ek/LIC (Novagen, 5.917 bp). This vector was 
selected because it generates thioredoxin fusion proteins, which was expected to 
contribute increasing protein solubility in E. coli. Futhermore, this vector contains two 
histidine tags that allowed purifying the protein later by nickel affinity chromatography. 
For subcloning, 400 ng cDNA and 500 ng pET-32 Ek/LIC vector were subsequently 
digested with 10 IU of the restriction enzyme XhoI (Fermentas) and then with 10 IU of 
KpnI (Promega) according to the manufacturer’s instructions. Digested fragments were 
purified with the DNA PuriPrep-GP Highway kit and Pure Link kit (Invitrogen) 
respectively. Ligation was carried out in a 1:5 relation with T4 DNA Ligase enzyme (3 
IU/μL, Promega) and 100 mM ATP and incubating ON at 18 °C. DH5α competent cells 
were transformed with the putative FNIIx4-pET-32 Ek construction. The colonies were 
analyzed using Colony PCR with the first specific Fw primer of the ELBSP1 cDNA and 
as the RV Terminator T7 primer from the vector. The putative positive clones (product 
amplification size of 729 bp) were then analyzed using a DNA sequencing service 
(Macrogen, Korea) to discard mutations. Sequences were analyzed using the BioEdit 
Sequence Alignment program. 
 
2.3. Protein cDNA over expression and purification 
Rosetta™ E. coli competent cells (Novagen) were transformed using thermal 
shock with 50 ng of the plasmid containing the FNIIx4-pET-32 Ek construction. From an 
isolated colony, cultures were grown in liquid LB medium supplemented with 100 μg/mL 
ampicillin and 20 μg/mL chloramphenicol and incubated at 37 °C utilizing agitation for 16 
h. A 25 mL of LB medium with the corresponding antibiotics was inoculated (1/100) and 
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incubated at 37 °C while stirring the medium until the OD = 0.4. Subsequently, the 
incubation continued at 18 °C until there was an OD = 0.6. The cultures were induced 
with 0.1 mM isopropyl-b-D-thiogalactoside (IPTG) and incubated 16 h at 18 °C until there 
was an OD = 2. Cells were harvested by centrifugation at 1700 x g for 15 min and re-
suspended in lysis buffer (phosphate-buffered saline, pH 7.4 containing 1 mg/mL 
lysozyme, 2.5% v/v triton and 0.5 mM PMSF) and subsequently lysed using sonication 
(ten cycles of 60 Hz power of 30 s). The cell lysate was centrifuged (13,000 x g, 
30 min) to separate supernatant from pellet. Both, soluble and insoluble fractions were 
separated using 12% w/v SDS-PAGE to verify the expression of the cDNA for the protein 
of interest. 
To recover TrxA-FNIIx4-His6 from the inclusion bodies, the insoluble fraction 
was washed twice in washing buffer I (20 mM Tris-HCl, pH 8, 20,000 x g, 30 min at 4 
°C) and was subsequently placed in washing buffer II to denature and solubilize the 
proteins (50 mM Tris, 50 mM ClNa, 1.5 mM β-mercaptoethanol, 2 M urea, 2 % v/v triton, 
pH 8, 20,000 x g, 30 min at 4 °C). Subsequently, the cell pellet was re-suspended in 
binding buffer (50 mM Tris, 500 mM ClNa, 10 mM β-mercaptoethanol, 8 M urea, 20 mM 
imidazole), stored for 1 h while stirring the medium at 4 ºC and centrifuged at 40,000 x 
g to separate the supernatant. 
The TrxA-FNIIx4-His6 purification was conducted using a HiTrap nickel affinity 
column (GE Healthcare) equilibrated with binding buffer. Refolding of the bound protein 
was induced using an on-column decreasing linear gradient of 14 mM urea/min from 
binding buffer to a buffer without urea and dihydrotreithol (50 mM Tris, 500 mM NaCl, 20 
mM imidazole) with a total volume of 300 mL for 12 h. The refolded protein was eluted 
with a gradient elution buffer containing increasing concentrations of imidazole (50 mM 
Tris-HCl, 500 mM NaCl with100 mM, 200 mM or 400 mM imidazole, respectively). Eluted 
fractions were pooled, dialyzed against 50mM phosphate buffer pH 7.5 and analyzed 
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using 12% (w/v) polyacrylamide gel. Protein concentration was quantified using the by 
Bradford method (Bradford, 1976). 
 
2.4. Sperm collection and freezing-thawing procedure 
All animals used in this study were managed in strict accordance with good 
animal practice and the conditions approved by the Animal Ethics Committee at INTA, 
Argentina. Semen collections were made from five fertile mature (5 years old) Texel 
rams, with a mean body condition score of 2.9 ± 0.8 (scale 1–5) housed at the 
Experimental Station of Balcarce (Instituto Nacional de Tecnología Agropecuaria, INTA 
Argentina; 37°450 south, 58°180 west), during the natural breeding season (March-June; 
autumn). Ejaculates were obtained using an artificial vagina. At least three samples with 
a sperm mass motility ≥ 4 (scale of 1 to 5) and concentration of ≥ 3 x 109 cells/mL were 
included in a semen pool for each week and there were 3 weeks of collections conducted. 
Each semen pool was composed of one ejaculate from at least three of the five rams 
used in the study. The composition of pools was different each week, as rams were 
selected randomly. Pooled ejaculates were diluted at 35 °C in one step with a TRIS-
glucose-citric acid extender supplemented with egg yolk (10 % v/v) and glycerol (7 % 
v/v) and cooled to 5 °C for 2 h. Samples were subsequently stored at 5 °C for 2 additional 
hours before freezing and packaging in 0.25 mL plastic straws. Semen samples were 
packaged at a final concentration of 100 x 106 spermatozoa/mL, corresponding to 25 x 
106 spermatozoa per straw. Straws were sealed with polyvinyl alcohol and frozen in liquid 
nitrogen vapors, 5 cm above the liquid nitrogen surface for 10 min, before being plunged 
into the liquid nitrogen for storage.  
 
2.5. Experimental design 
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Different sperm variables were evaluated to study the effect of the recombinant 
protein over post-thawed sperm. Two different protein concentrations were assayed and 
compared to a control group without protein. To define the concentrations of the protein 
to be evaluated, a dose response assay for sperm viability was conducted using a 
subjective motility analysis as follows: 5 µl of semen was placed on a pre-warmed glass 
slide with a cover slip being applied and there was visual assessment using a phase-
contrast microscope (4009; Nikon Diaphot, Japan). The initial dose of TrxA-FNIIx4His6 
that was evaluated was similar to that reported by Barrios et al. (2005) for RSVP14 (13 
μM). The following doses were assessed: 13, 6.5, 3, 1.5, 0.3 and 0.15 µM. Because of 
the complete loss of sperm viability (evaluated as subjective total motility) after an 
incubation of 30 min at 37 °C with the greater concentrations, the decision was made to 
use 0.15 μM and 0.3 μM in the assays for the present study.  
Regarding the assessment of the effects of recombinant protein when 
considering the various sperm variables, three straws were randomly thawed by 
immersion in a water bath (37 °C, 20 s), layered over 1 mL Androcoll-OTM colloid and 
centrifuged to remove dead cells and SP (800 x g by 5 min and then 1200 x g for 10 
min), and subsequently sperm cells were washed with PBS (800 x g, 5 min) and 
incubated at 37 ºC in PBS. At the initiation of the incubation period, there was addition 
of the protein immediately after the selection process. At the indicated times for each 
assay, an aliquot was collected. The evaluation of sperm motility was performed at 30, 
60, 90 and 120 min of the incubation period, phosphorylation status was assessed after 
60 min incubation as previously described (Ledesma et al., 2016) and in vitro fertilization 
was evaluated after 40 h of incubation. There were three experimental replicates for each 
assay. Within each replicate, straws from the same pool of semen were used to evaluate 
the different sperm variables.  
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2.6. Fluorescent labeling and binding of TrxA-FNIIx4-His6x to spermatozoa 
The TrxA-FNIIx4-His6 (1.32 µM) was incubated with 130 mM FITC (in DMSO) in 
0.1M buffer Sodium bicarbonate (pH 9.2, 2 h, room temperature). Non-conjugated dye 
was subsequently removed by dialysis against 50 mM buffer phosphate pH 7.5 
containing 0.15 M of NaCl. The protein labeling was confirmed by evaluating the 
absorption spectrum (280-500 nm). To evaluate the interaction of FITC-TrxA-FNIIx4-His6 
with ram the sperm cells, 2 x 108 frozen/thawed sperm were incubated with 0.37 µM 
FITC-TrxA-FNIIx4-His6 solution in PBS during 15 min at room temperature as previously 
described for recombinant SPINK3 (Zalazar et al., 2016). There was also inclusion of a 
group where sperm were incubated with unlabeled protein as a control of 
autofluorescence. Furthermore, there was incubation of sperm with FITC and without 
protein as a specificity control. Samples were then fixed in 4 % (v/v) formaldehyde and 
washed in PBS (600 x g, 5 min). Binding was confirmed using fluorescence visualization 
under confocal microscope (600 x) (Nikon C1siR). Images were analyzed using the 
ImageJ free software (https://imagej.nih.gov/ij/).  
 
2.7. Sperm analyses 
2.7.1. Capacitation status by phosphorylation of PKA substrates 
Thawed sperm (5 x 106) were treated with 0.15 or 0.3 µM of recombinant 
protein for 60 min at 37 °C and then centrifuged at 7500 x g 5 min at 4 °C. Sperm pellets 
were mixed with 5X Laemmli sample buffer under reducing conditions (100 mM DTT) 
and boiled for 5 min. Solubilized proteins were separated by electrophoresis on 10 % 
(w/v) acrylamide SDS–PAGE (Laemmli et al., 1970) and transferred to Immuno-Blot 
251PVDF membranes (BIO-RAD). Non-specific binding sites on membranes were 
blocked with 5 % w/v BSA in TBS-T (10 mM Tris–HCl, pH 8, 120 mM NaCl, 0.05 % 
Tween) for 60 min h at room temperature. There was immuno-detection of 
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phosphorylated proteins in PKA substrates by incubating with the primary antibody 
(AntiPKA monoclonal mouse, Santa Cruz, 1:500 in blocking solution), overnight at 4 °C 
with constant agitation of medium occurring. After three washes in TBS-T, the 
membranes were incubated for 60 min at room temperature with the secondary antibody 
(anti-mouse IgG conjugated with HRP, BioRad, 1:10000 in blocking solution). The 
membranes were developed using the C-DiGit Chemiluminescent Western Blot Scanner 
(LI-COR). Blots were subsequently stripped for 20 min at 60 °C using a stripping buffer 
(62.5 mM Tris-HCl, 2 % w/v SDS, 100 mM β-mercaptoethanol, pH 6.5), re-blocked and 
sequentially incubated overnight with a mouse monoclonal anti-tubulin antibody (1:5000) 
(Sigma, T6094). Secondary antibody incubation and development were performed as 
previously described in this manuscript. Chemiluminescence was developed in a C-Digit 
blot Scanner (Li-Cor, US) and images were analyzed using Image Studio Lite 5.0. Bands 
intensities per area unit were normalized to the corresponding tubulin densities. 
 
2.7.2. Sperm motility variables 
Objective motility was evaluated every 30 min up to 120 min of incubation by 
using a CASA computerized analysis system developed by Buchelly Imbachi et al. 
(2018). Aliquots of 1 x 109 spermatozoa were treated with 0.15 μM, 0.3 μM of TrxA-
FNIIx4-His6 or without protein at 37 °C in PBS. A Cell-Vu chamber (20 μm, Millennium 
Sciences) warmed to 37 °C, was filled with 7 μL of sample and examined using a 10 X 
objective (negative phase contrast field) on a Nikon Eclipse E200 microscope. Images 
were captured with a Coolpix S10, Nikon digital camera at 30 frames per second (fps). 
Four fields containing among 700 and 2000 cells were analyzed for each treatment, time 
and replicate. The kinematic variables were analyzed for each spermatozoon were: total 
motility (TM; %), progressive motility (PM; %), straight-line velocity (VSL; μm/s), 
curvilinear velocity (VCL; μm/s), velocity path average (VAP; μm/s), linearity (LIN; %), 
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straightness (STR; %), wobble (WOB; %), amplitude of the lateral movement of the head 
(ALH; μm) and beat-cross frequency (BCF; Hz).  
 
2.7.3. Fertilization potential 
To evaluate sperm fertilizing potential, the heterologous in vitro fertilization 
described by García-Alvarez et al. (2009) with modifications was used. Bovine ovaries 
were collected from a local slaughterhouse and transported within 2 h in a thermic 
container at room temperature. Cumulus–oocyte complexes (COCs) with 
homogeneous ooplasm and more than four complete layers of cumulus cells, 
corresponding to grade 1 and 2 according to De Loos et al. (1989), were selected using 
a stereomicroscope and washed three times in M199 supplemented with 0.5 % HEPES 
(w/v). COCs were cultured in TCM199 supplemented with 50 lg/mL gentamycin, 5.5 
mM Ca lactate, 2.3 mM Na pyruvate, 36 mM NaHCO3, 5 mM Hepes, 0.01 UI/mL rhFSH 
(Gonal F-75, Serono, UK). Maturation was induced in four-well plates (Nunc, Roskilde, 
Denmark) in groups of 50 to 60 COCs with 400 µl of maturation media for 24 h at 38.5 
°C under 5 % CO2 in air with maximum humidity. Matured COCs were transferred to 
400 µL of fertilization medium (SOF supplemented with 10% of estrous sheep serum 
and 40 µg/ml gentamycin). Thawed ram sperm were selected on a Percoll 
discontinuous density gradient (45/90) and capacitated in the fertilization medium for 
10 min. Sperm was co-incubated with oocytes at a final concentration of 2.5 x 105 
cells/mL per 40-50 COCs at 38.5 °C in 5 % CO2 for 40 h, in the presence or absence 
of 0.15 μM or 0.3 μM TrxA-FNIIx4-His6. To discount any parthenogenic effect of the 
recombinant protein, a control was performed supplementing un-inseminated oocytes 
with the same concentrations of TrxA-FNIIx4-His6. After co-incubation, oocytes were 
fixed in 400 µL of glutaraldehyde and stained with Hoechst 33342. Fertilization rate was 
assessing after 40 h using an inverted microscope by assessing the presence of 
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cleaved oocytes (two to eight cells) or the presence of two or more nuclei.  
 
2.8. Statistical analysis 
Data were analyzed using a generalized linear mixed effect model for continuous 
response variables of the statistical package SAS (Statistical Analysis System version 
8.2 (SAS). The statistical model included the effect of the addition of TrxA-FNIIx4-His6 in 
two concentrations 0.15 μM and 0.3 μM and the effect of the time (discrete variable). To 
test normality and homoscedasticity, a histogram and plot of residuals for each model 
was performed. When model assumptions were not fitted, data were transformed by 
square root function. Results were expressed as least square means (LSM) ± standard 
error of means (SEM). Differences were considered to exist P ≤ 0.05. 
 
3. Results 
3.1. Construction of the cDNA and expression of recombinant TrxA-FNIIx4-His6   
The cDNA encoding four tandem FNII repeats from ELSPBP1 was amplified from 
a bovine epididymal cDNA library (figure 1) with specific primers obtaining a product of 
597 bp and sub-cloned in the expression vector pET-32 Ek/LIC (Figure 2). The resulting 
recombinant TrxA-FNIIx4-His6 cDNA was expressed in competent E. coli Rosetta. As 
the protein was detected primarily within inclusion bodies, there was a denaturation and 
on-column refolding-purification protocol applied using nickel affinity chromatography 
(Figure 2). 
 
3.2. Analysis of the TrxA-FNIIx4-His6 binding to spermatozoa 
The  sperm  binding  capacity  of  the purified TrxA-FNIIx4-His6 was assessed 
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by incubating  thawed  ram  spermatozoa  (2 x 108 cells/mL) with 2.8 µM FITC-
conjugated-TrxA-FNIIx4-His6. With use of fluorescence confocal microscopy analysis, 
there were differences detected in the intensity and distribution patterns of fluorescence 
for sperm incubated with and without TrxA-FNIIx4-His6 having a greater fluorescence 
intensity when TrxA-FNIIx4-His6 was attached to sperm (Figure 3). Fluorescence was 
observed mainly in the acrosomal region and middle piece, which is consistent with what 
occurs with the native protein ELSBP1 and other proteins with FNII domains (Ekhlasi‐
Hundrieser et al., 2007; Plante et al., 2014). 
 
3.3. Analysis of TrxA-FNIIx4-His6 capacity to repair sperm cryodamage 
 
3.3.1. Capacitation status 
To evaluate the possible effect of the recombinant protein on the reversion or 
minimization of cryo-capacitation molecular signals, the status of substrates 
phosphorylated by the cAMP-dependent protein kinase (PKA) were analyzed. Proteins 
extracted from post-thawed sperm previously incubated for 60 min with or without 0.15 
μM or 0.3 μM of TrxA-FNIIx4-His6 were analyzed using western blot procedures. A 
pattern with four defined and quantifiable bands was detected in each treatment (Figure 
4). Densitometry assessments of each band indicated that there were differences in 
the intensities of all bands (approximately 102, 76, 52 and 31 kDa) detected for 
substrates phosphorylated as a result of PKA (P <0.05) between treatments and 
control. With use of the two concentrations of TrxA-FNIIx4-His6 evaluated, there was a 
reduction of the phosphorylation signal. Conversely, there was no statistical differences 
when the two concentrations of TrxA-FNIIx4-His6 were evaluated (Figure 4). 
 
3.3.2. Sperm motility 
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Considering sperm motility is the most frequently assessed variable for 
determination of cell quality, different kinetic variables were evaluated using CASA 
every 30 min during the 120 min of the incubation period (37 °C) in thawed spermatozoa 
supplemented with TrxA-FNIIx4-His6. Results were contrasted with those of untreated 
sperm (control). There was no significant beneficial effect of TrxA-FNIIx4-His6 on sperm 
motility percentages or values for kinetic variables at any of the evaluation periods 
(Figure 5, Table 1). 
 
3.3.3. Fertilizing potential 
Considering that TrxA-FNIIx4-His6 is a decapacitating protein, it was important to 
evaluate the fertilization capacity of the treated sperm. For this, a heterologous in vitro 
fertilization assessment was conducted (García-Alvarez et al., 2009). Addition of 0.3 µM 
of TrxA-FNIIx4-His6 induced an increase in fertilization rate compared to control samples 
(P = 0.024) because there were a greater number of cells where cleavage had occurred 
and/or there was the presence of two or more nuclei. There, however, were no 
differences in cleavage rates between sperm treated with 0.15 µM of TrxA-FNIIx4-His6 
and control samples (Figure 6).  
 
4. Discussion  
The results from the present study indicate there can be cloning, expression 
of an encoding cDNA and purification of a recombinant peptide composed of four 
tandem FNII domains as a first approach to create a media with defined 
composition that can protect/reverse the damage caused by cryopreservation. The 
cDNA fragment was obtained from a bovine epididymis library constructed and the 
resulting recombinant peptide had the capacity to bind to frozen/thawed ram sperm 
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at the acrosomal region and the midpiece, reversed cryo-capacitation indicators 
and improved in vitro fertilization when added at 0.3 µM to fertilization media. Sperm 
motility, however, was not affected by the treatment at any of the concentrations 
assayed. 
For several years, additives for freezing/thawing media have been studied to 
prevent/reverse the undesirable effects of cryopreservation on sperm cells (Kumar and 
Atreja 2012; Mukherjee et al., 2016; Zalazar et al., 2016; Del valle et al., 2017; İnanç et 
al., 2018). Cryo-capacitation, a premature capacitation-like status, reduces the functional 
sperm lifespan decreasing the fertilization potential when these sperm are used for 
artificial insemination. Preventing and even reversing this cryo-damage allowing the 
normal capacitation (physiological) to occur when the sperm are located in the oviduct 
with the oocyte is the desired outcome with the use of these treatments. Because SP is 
known to contain decapacitating proteins, the addition of SP has been used prior to 
freezing/after thawing to prevent/reverse molecular changes as a result of cryo-
capacitation such as protein phosphorylation in several species such as rams (Pérez-Pé 
et al., 2001), boars (Vadnais and Althouse, 2011) and horses (De Andrade et al., 2012). 
The effect of SP, however, depends on its variable composition, making it difficult to 
obtain consistent results when using these approaches. The capacity of SP to protect 
and reverse the damage caused by freezing/thawing has been attributed to a group of 
SP proteins that interact with membrane components of the sperm. Most of these 
proteins belong to BSP (Binder of Sperm Proteins) family characterized to contain two 
or four fibronectin type II domains, which mediate the interaction with spermatozoa 
through choline phospholipids of the sperm membrane (Plante et al., 2016). Serrano et 
al. (2013) cloned and expressed two proteins from this family, RSVP14 and RSVP20 
(Serrano et al., 2015). The effect of inclusion of these proteins in the freezing/thawing 
media, however, has not yet been reported and the mechanism of action of these 
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recombinant proteins remains unknown. 
Most recombinant proteins for biotechnological purposes are produced in E. coli 
(Ferrer-Miralles et al., 2009) due to relatively lesser cost as compared with other 
procedures and protein production efficiencies when using this approach. This protein 
production approach, however, jeopardizes the occurrence of post-translational 
modifications such as formation of di-sulfide bridges (Wilkinson and Harrison, 1991). In 
the present study, despite the addition of a thioredoxin tag (La Vallie et al., 1993), the 
recombinant peptide was expressed in the insoluble fraction using all the conditions 
utilized (data not shown). Solubilized and refolded TrxA-FNIIx4-His6 bound to the head 
and midpiece, as reported for other proteins with FNII domains in bull, mice and human 
sperm (Plante et al., 2012). As reported by Barrios et al. (2005) for RSVP14, in the 
present study there was evaluation of the addition of 13 μM of TrxA-FNIIx4His6 in the 
thawing media, however, there was loss of sperm motility completely after 30 min of 
incubation at 37 °C. The doses used in the present study were similar to those used by 
Serrano et al. (2013) where there was expression of recombinant RSVP14.  
In regard to results from the sperm motility CASA assessments in the present 
study, there was no difference between control and sperm supplemented with TrxA-
FNIIx4His6 neither for population nor values for kinetic variables at any of the incubation 
periods and concentrations evaluated. This finding is similar to those from a previous 
study (Ledesma et al., 2016), in which the addition of a fraction of seminal plasma 
proteins that interact with sperm surface that is known to be rich in FNII containing 
proteins (Bernardini et al., 2011) did not modify mitochondrial potential and sperm 
motility. This result indicates that the lack of effect for these variables was not due to the 
presence of other components of SP present in enriched fraction, but instead, it may 
explain that this domain did not function at the mitochondria, or there may be actions of 
this protein only at a subpopulation of sperm in the samples. 
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In the present study, the addition of 0.15 and 0.3 µM of TrxA-FNIIx4His6 reversed 
the phosphorylation of some PKA substrates. Protein kinase A (PKA) is known to be 
responsible for the phosphorylation of proteins at Ser and Thr residues (Visconti et 
al., 2011) as part of the signal transduction pathway when the normal capacitation 
processes occur in the oviduct. Although there are some similarities between in vitro 
capacitation and cryo-capacitation such as plasma membrane reorganization, increase 
in [Ca2+]i and occurrence of protein phosphorylation, there are striking difference in 
pattern of phosphorylation and it should not be considered as the same capacitation 
process that occurs for sperm in the oviduct after insemination of the female (Green and 
Watson, 2001; Kumar and Atreja, 2011; Pommer and Meyers, 2002). The effect of 
reducing phosphorylation that occurred in the present study are consistent with those 
reported previously after supplementation of ram sperm with seminal plasma proteins 
that interact with the sperm surface (Ledesma et al., 2016). The advantages of reversing 
cryo-capacitation in ram sperm was previously reported by other groups. Fang et al. 
(2018) reported that addition of boar SP inhibited cryo-capacitation of frozen-thawed ram 
sperm while improving the normal physiological capacitation process at in vitro 
capacitating conditions, increased sperm penetration and pregnancy rate when there 
was intra-cervical AI conducted. The use of a recombinant peptide, however, has the 
advantages related with the production practices and the capacity to have a more 
precisely defined composition. There has been identification as a result of a recent 
proteomics study of a tyrosine-protein kinase isoform X2 and a phospholipid scramblase 
isoform X1 with use of LC-MS/MS and SWATH and there were different quantities in 
lysates of ram spermatozoa after cryopreservation (Pini et al., 2018) with both alterations 
being related to cryo-capacitation. The FNII rich proteins might function to reverse these 
variations as a result of the affinity of these proteins for sperm membrane phospholipids. 
The promising results of the present study regarding the decapacitating effect of 
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TrxA-FNIIx4His6 were associated with improvements in the in vitro fertilization rate when 
the treated sperm were used for this purpose. Addition of 0.3 μM of TrxA-FNIIx4His6 to 
the spermatozoa improved the fertilization rate compared with control. To the best of our 
knowledge, this is the first study where it has been reported that the addition of a 
recombinant peptide resulted in improvements in the fertilizing potential of frozen/thawed 
sperm. Decapacitating proteins are known to be removed from the sperm surface on the 
female reproductive tract environment and/or in the oviduct where the ovum is located 
prior to the time of fertilization (Mannowetz et al., 2011; Young et al., 2009). As a result, 
the TrxA-FNIIx4-His6 protein supposedly has a de-capacitating activity in sperm media; 
however, it is supposed to detach from the sperm during the FIV co-culture. Obviously, 
video imaging is needed to confirm that there is detaching of TrxA-FNIIx4His6 from the 
fertilizing sperm. Because capacitation is a known pre-requisite for fertilization, the 
results of the present study not only confirm that the protein did not prevent physiological 
capacitation but also improved the percentage of sperm with the capacity for fertilization 
as evidenced by the IVF results. It has to be noted that although both TrxA-FNIIx4His6 
doses reduced protein phosphorylation, only at the larger doses were there the more 
desirable results with the IVF assay. It is not surprising that there were no indications 
with the Western blot analysis of a dose-response effect when due to background 
phosphorylation induced by freezing because the treatment cannot affect the whole 
sperm. 
In view of the results of the present study, there was cloning of a cDNA and 
expression resulting in the production of a peptide containing four domains of type II 
fibronectin fused to a thioredoxin and a tag of six terminal histidines, named TrxA-
FNIIx4-His6. As a promising biotechnique, further analyzes of post thawing sperm 
variables using flow cytometry (plasma membrane permeability, mitochondrial activity, 
membrane fluidity, production of intracellular reactive oxygen species) needs to occur 
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and furthermore, incorporation of the recombinant peptide into the freezing extender is 
planned for future research. 
 
Declaration of interest 
The authors have not declared any conflicts of interest. 
 
Acknowledgements 
We especially thank Adriana Cano for her kind support on statistical analysis. 
This research is part of a thesis by Alba Ledesma in partial fulfillment of the requirements 
for the Doctor’s degree of Facultad de Ciencias Agrarias, Universidad Nacional de Mar 
del Plata, Argentina. This research was supported by National Agency for Scientific and 
Technological Promotion (ANPCyT, PICT-2015-3682) and National Scientific and 
Technical Research Council (CONICET, Argentina, PIP 2014-0273) grants. 
 
References 
Bailey, J., Morrier, A., Cormier, N., 2003. Semen cryopreservation: successes and 
persistent problems in farm species. Can J. Anim. Sci. 83, 393-401. 
Barrios, B., Pérez-Pé, R., Gallego, M., Tato, A., Osada, J., Muiño-Blanco, T., Cebrián 
Pérez, J., 2000. Seminal plasma proteins revert the cold-shock damage on ram 
sperm membrane. Biol. Reprod. 63, 1531-1537. 
Barrios, B., Fernández-Juan, M., Muiño-Blanco, T., Cebrián-Pérez, J., 2005. 
Immunocytochemical localization and biochemical characterization of two 
seminal plasma proteins that protect ram sperm against cold shock. J. 
Androl. 26, 539-549. 
AC
CE
PT
ED
 M
AN
US
CR
IPT
22 
 
Bernardini, A., Hozbor, F., Sánchez, E., Fornes, M., Alberio, R., Cesari, A., 2011. 
Conserved ram seminal plasma proteins bind to the sperm membrane and 
repair cryopreservation damage. Theriogenology 76, 436-447. 
Bradford, M., 1976. A rapid and sensitive method for the quantification of microgram 
quantities of protein utilizing the principle of protein-dye binding. Anal. 
Biochem. 72, 248-254. 
Buchelly Imbachí, F., Zalazar, L., Pastore, J., Greco, M., Iniesta-Cuerda, M., Garde, 
J. Soler, A., Ballarin, V., Cesari, A., 2018. Objective evaluation of ram and 
buck sperm motility by using novel sperm tracker software. Reproduction 156, 
11-21. 
Chakrabarty, J., Banerjee, D., Pal, D., Majumbder., 2007. Shedding off specific lipid 
constituents from sperm cell membrane during cryopreservation. Cryobiology 
64, 27-35. 
Colás, C., Junquera, C., Pérez-Pé, R., Pérez, J., Muiño-Blanco, T., 2009. 
Ultrastructural study of the ability of seminal plasma proteins to protect ram 
spermatozoa against cold-shock. Microsc. Res. Techniq. 72, 566-572. 
Curry, M. R., 2007. Cryopreservation of mammalian semen. In: Cryopreservation and 
Freeze-Drying Protocols (pp. 303-311). Humana Press. 
De Andrade, A., Zaffalon, F., Celeghini, E., Nascimento, J., Bressan, F., Martins, S., 
De Arruda, R., 2012. Post-thaw addition of seminal plasma reduces tyrosine 
phosphorylation on the surface of cryopreserved equine sperm, but does not 
reduce lipid peroxidation. Theriogenology 77, 1866-1872. 
de Loos, F., van Vliet, C., van Maurik, P., Kruip, T. A. 1989. Morphology of immature 
bovine oocytes. Gamete Res. 24, 197-204. 
Del Valle, I., Casao, A., Pérez-Pé, R., Holt, W., Cebrián-Pérez, J., Muiño-Blanco, T., 
2017. Seminal Plasma Proteins Prevent Detrimental Effects of Ram Sperm 
AC
CE
PT
ED
 M
AN
US
CR
IPT
23 
 
Cryopreservation and Enhance the Protective Effect of Lecithin. Biochem. 
Anal. Biochem. 6, 2161-1009.  
Desnoyers, L., Manjunath, P., 1992. Major proteins of bovine seminal plasma exhibit 
novel interactions with phospholipid. J. Biol. Chem. 267, 10149-10155. 
Domínguez-Rebolledo, A., Navarrete Sierra, L., Cruz Tamayo, A., Aguiar Lorio, A., 
Erosa Denis, S., Bolio Oses, R., González Parra, E., Paredes Monsreal, L., 
Ramón Ugalde, J., 2007. Fertilidad en ovejas de pelo inseminadas con 
semen congelado rediluido con plasma seminal. Revista Científica. 17, 73-
76. 
Domínguez, M., Falcinelli, A., Hozbor, F., Sanchez, E., Cesari, A., Alberio, R., 2008. 
Seasonal variations in the composition of ram seminal plasma and its effect 
on frozen-thawed ram sperm. Theriogenology 69, 564-573. 
Ekhlasi‐Hundrieser, M., Schafer, B., Philipp, U., Kuiper, H., Leeb, T., Mehta, M., 
Kirchhoff, C., Topfer‐Petersen, E., 2007. Sperm‐binding fibronectin type II‐
module proteins are genetically linked and functionally related. Gene 392, 
253-265.  
Fang, Y., Zhong, R., Zhang, X., Zhang, J., Zhou, D., 2018. Boar seminal plasma 
inhibits cryo-capacitation of frozen-thawed ram sperm and improves fertility 
following intracervical insemination. Theriogenology 105, 84-89 
Ferrer-Miralles, N., Domingo-Espin, J., Corchero, J., Vázquez, E., Villaverde, A., 
2009. Microbial factories for recombinant pharmaceuticals. Microb. Cell. Fact. 
8, 17-25. 
García-Álvarez, O., Maroto-Morales, A., Martínez-Pastor, F., Fernández-Santos, M., 
Esteso, M., Pérez-Guzmán, M., Soler, A., 2009. Heterologous in vitro 
AC
CE
PT
ED
 M
AN
US
CR
IPT
24 
 
fertilization is a good procedure to assess the fertility of thawed ram 
spermatozoa. Theriogenology 71, 643-650.  
Green, C., Watson, P, 2001. Comparison of the capacitation-like state of cooled boar 
spermatozoa with true capacitation, Reproduction 122, 889-898;  
Hagiwara, M., Choi, J., Devireddy, R., Roberts, K., Wolkers, W., Makhlouf, A., 
Bischof, J., 2009. Cellular biophysics during freezing of rat and mouse sperm 
predicts post-thaw motility. Biol. Reprod. 81, 700-706. 
İnanç, M., Uysal, O., Ata, A., 2018. Cryopreservation and evaluation of Akkaraman 
ram semen with 7-dehydrocholesterol. Ankara Üniversitesi Veteriner 
Fakültesi Dergisi, 65, 187-192. 
Kumar, R.; Atreja, S., 2012. Effect of Incorporation of Additives in tris-based egg yolk 
extender on Buffalo (Bubalus bubalis) sperm tyrosine phosphorylation during 
cryopreservation. Reprod. Dom. Anim. 47, 485-490. 
Laemmli, U., Beguin, F., Gujer-Kellenberg, G., 1970. A factor preventing the major 
head protein of bacteriophage T4 from random aggregation. J. Mol. Biol. 47, 
69-85. 
La Vallie, E., Di Blasio, E., Kovacic, S., Grant, K., Schendel, P., Mc Coy, J., 1993. A 
thioredoxin gene fusion expression system that circumvents inclusion body 
formation in the E. coli cytoplasm. Nat. Biotechnol. 11, 187-193. 
Ledesma, A., Fernández-Alegre, E., Cano, A., Hozbor, F., Cesari, A., Martínez-
Pastor, F., 2016. Seminal plasma proteins interacting with sperm surface 
revert capacitation indicators in frozen-thawed ram sperm. Anim. Reprod. 
Sci. 173, 35-41. 
Maldjian, A., Pizzi, F., Gliozzi, T., Cerolini, S., Penny, P., Noble, R., 2005. Changes 
in sperm quality and lipid composition during cryopreservation of boar semen. 
Theriogenology 63, 411-421. 
AC
CE
PT
ED
 M
AN
US
CR
IPT
25 
 
Manjunath, P., Therien, I., 2002. Role of seminal plasma phospholipid-binding 
proteins in sperm membrane lipid modification that occurs during 
capacitation. J. Reprod. Immunol. 53, 109-119. 
Mannowetz, N., Wandernoth, P., Hornung, J., Ruffing U., Raubuch, M., Wennemuth, 
G., 2011. Early activation of sperm by HCO3- is regulated hormonally in the 
murine uterus. Int. J. Androl. 34, 153–64.  
Maxwell, W., De Graaf, S., Ghaoui, R., Evans, G., 2007. Seminal plasma effects on 
sperm handling and female fertility. Soc. Reprod. Fert. 64, 13. 
Mendoza, N., Casao, A., Pérez-Pé, R., Cebrián-Pérez, J., Muiño-Blanco, T., 2013. 
New insights into the mechanisms of ram sperm protection by seminal plasma 
proteins. Biol. Reprod. 88, 1-15. 
Mukherjee, K., Basu, S., Sahoo, A., Datta, U., Ray, K., Chattaraj, S., 2016. 
Cryoprotective effect of EDTA, lactose, ascorbic acid and L-cysteine as 
additives on garole ram (Ovis aries) semen. Int. J. Adv. Res. Biol. Sci, 3, 92-
98. 
Oldenhof, H., Friedel, K., Sieme, H., 2010. Membrane permeability parameters for 
freezing of stallion sperm as determined by Fourier transform infrared 
spectroscopy. Cryobiology 61, 115-122. 
Ollero, M., Cebrián-Pérez, J., Muiño-Blanco, T., 1997. Improvement of 
cryopreserved ram sperm heterogeneity and viability by addition of seminal 
plasma. J. Androl. 18, 732-739. 
Pérez-Pé, R., Cebrián-Pérez, J., Muiño-Blanco, T., 2001. Semen plasma proteins 
prevent cold-shock membrane damage to ram spermatozoa. Theriogenology 
56, 425-434. 
Pini, T., Rickard, P., Leahy, T., Crossett, B., Druart, X., de Graaf, S., 2018. 
Cryopreservation and egg yolk medium alter the proteome of ram 
spermatozoa. J. Proteom. 181, 73-82. 
AC
CE
PT
ED
 M
AN
US
CR
IPT
26 
 
Plante, G., Thérien, I., Manjunath, P., 2012. Characterization of recombinant murine 
binder of sperm protein homolog 1 and its role in capacitation. Biol. Reprod. 
87, 1-11. 
Plante, G., Fan, J., Manjunath, P., 2014. Murine Binder of Sperm Homolog 2 
(BSPH2): The Black Sheep of the BSP Superfamily. Biol. Reprod. 90, 20-21. 
Plante, G., Prud'homme, B., Fan, J., Lafleur, M., Manjunath, P., 2016. Evolution and 
function of mammalian binder of sperm proteins. Cell Tissue Res. 363, 105-
127. A.  
Pommer, A., Meyers, S., 2002. Tyrosine phosphorylation is an indicator of 
capacitation status in fresh and cryopreserved stallion spermatozoa, 
Theriogenology 58, 351-355. 
Reddy, N., Mohanarao, G., Atreja, S., 2010. Effects of adding taurine and trehalose 
to a tris-based egg yolk extender on buffalo (Bubalus bubalis) sperm quality 
following cryopreservation. Anim. Reprod. Sci. 119, 183-190. 
Said, T., Gaglani, A., Agarwal, A., 2010. Implication of apoptosis in sperm cryoinjury. 
Reprod. BioMed. 21, 456-462.  
Serrano, E., Martínez, A., Arruga, D., Pérez-Pé, R., Sánchez-Ferrer, A., Muiño-
Blanco, T., Pérez-Pé, J., 2015. New insights into the phylogeny and gene 
context analysis of binder of sperm proteins (BSPs). PLoS ONE. 10: 
e0137008. https://doi.org/10.1371/journal.pone.0137008.  
Serrano, E., Pérez-Pé, R., 2013. Characterization of the cDNA and in vitro 
expression of the ram seminal plasma protein RSVP14. Gene 519, 271-278. 
Singh, S., Atreja, S., Kumar, R., Chillar, S., Singh, A., 2012. Assessment of 
intracellular Ca2+, AMPc and 1,2 diacylglycerol in cryopreserved buffalo 
(Bubalus bubalis) spermatozoa on supplementation of taurine and trehalose 
in the extender. Reprod. Dom. Anim. 47, 584-590. 
Therien, I., Bergeron, A., Bousquet, D., Manjunath, P., 2005. Isolation and 
AC
CE
PT
ED
 M
AN
US
CR
IPT
27 
 
characterization of glycosaminoglycans from bovine follicular fluid and their 
effect on sperm capacitation. Mol. Reprod. Dev. 71, 97-106. 
Vadnais, M., Althouse, G., 2011. Characterization of capacitation, cryoinjury, and the 
role of seminal plasma in porcine sperm. Theriogenology 76, 1508-1516. 
Visconti, P., Krapf, D., De La Vega-Eltán, J., Acevedo, J., Darzon, A., 2011. Ion 
channels, phosphorylation and mammalian sperm capacitation. Asian J. 
Androl. 13, 395-405. 
Watson, PF. 1981. The effects of cold shock on sperm cell membranes. G.J. Morris, 
A. Clarke (Eds.), Effects of Low Temperatures on Biological Membranes, 
Academic Press, New York, NY (1981), pp. 189-218 
White, I., 1993. Lipids and calcium uptake of sperm in relation to cold shock and 
preservation: a review. Reprod. Fert. Dev. 5, 639-658. 
Wilkinson, D., Harrison, R., 1991. Predicting the solubility of recombinant proteins in 
Escherichia coli. Nat. Biotechnol. 9, 443-448. 
Young, C., Grasa, P., Coward, K., Davis, L., Parrington, J., 2009. Phospholipase C 
zeta undergoes dynamic changes in its pattern of localization in sperm during 
capacitation and the acrosome reaction. Fertil. Steril. 91, 2230–42. 
Zalazar, L., Ledesma, A., Hozbor, F., Cesari, A., 2016. Heterologous recombinant 
protein with decapacitating activity prevents and reverts cryodamage in ram 
sperm: an emerging biotechnological tool for cryobiology. Anim. Reprod 
Sci. 164, 31-39. 
  AC
CE
PT
ED
MA
NU
SC
RI
PT
28 
 
 
Figure legends 
 
Fig. 1. Bovine Epididymis cDNA library construction; Bioanalyzer electropherograms 
of total RNA, mRNA and cDNA fractions (A, B and C respectively); Panel D. depicts 
the range of inserts in 24 random clones from library after excision from the pDONR 
plasmid using the BsrG I restriction enzyme; Samples were processed using a 1.5% 
agarose gel compared to 1Kb ladder (Invitrogen) 
 
 
 
Fig. 2. Cloning, gene expression and purification of TrxA-FNIIx4-His6; A. cDNA 
encoding four tandem FNII repeats from Epididymal Sperm Binding Protein 1 
precursor (ELSPBP1) was amplified from a bovine epididymal cDNA library and 
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cloned into the expression vector pET-32 Ek/LIC (Novagen, 5.917 bp); Construction 
included a thioredoxin tag (TrxA) at the N-terminal and a 6 Histidine tag (Hisx6) at 
the C-terminal; B. E. coli Rosetta cells were transformed with the construction FNIIx4-
pET-32 Ek; Electrophoretic profile using SDS–PAGE indicates the soluble (S) and 
insoluble (I) fractions of E. coli cells after 16 h induction (+IPTG T16) with 0.1 mM 
IPTG at 18 °C; A soluble fraction of cells without induction is depicted (control); TrxA-
FNIIx4-His6 protein solubilized from inclusion bodies was refolded and purified using 
a HiTrap nickel affinity column (Purification); Molecular weight marker is depicted at 
left; Arrow indicates the expected size for the protein (38 kDa) 
 
 
 
Fig. 3. Interaction between FITC-TrxA-FNIIx4-His6 and thawed ram sperm using 
fluorescence confocal microscopy; Thawed ram sperm (20 x 106 cells/mL) were 
incubated with 25 µg 0 . 3 7 µ M FITC-TrxA-FNIIx4-His6 during 60 min at room 
temperature and fixed; Left panel:  Spermatozoa incubated with FITC-TrxA-FNIIx4-
His6 (TrxA-FNIIx4-His6) or FITC without protein (control) were visualized using a 
microscope (60x); Right panel: The graph depicts the distribution fluorescence intensity 
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from the apical region to the flagella of each sperm; Upper line corresponds to 
spermatozoa incubated with FITC-TrxA-FNIIx4-His6 and bottom line corresponds to 
control 
 
 
 
Fig. 4. Phosphorylated PKA substrates pattern in frozen/thawed ram sperm; A. 
Phosphorylation was detected by western blot using an antibody anti-PKA on total 
proteins obtained after 60 min incubation of frozen/thawed ram sperm with 0.15 µM 
(Lane 1), 0.3 µM TrxA-FNIIx4-His6 (Lane 2) and contrasted with control without protein 
(Lane 3); Experiment was performed three times and a representative western blot 
is included; B. Quantification of signal intensity detected for each protein band (1-4) 
was normalized to the corresponding tubulin densities; Mean values ± SEM of each 
phosphorylation signal band (area x intensity); For each protein band, different 
superscripts letters indicate differences between treatments 
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Fig. 5. Motility analysis on frozen/thawed ram sperm treated with TrxA-FNIIx4-His6; 
Thawed spermatozoa were incubated with or without 0.15 μM, 0.3 μM of TrxA-FNIIx4-
His6 at 37 °C in PBS for 30, 60, 90 and 120 min; Values for kinetic variables VSL (A), 
VCL (B), VAP (C), ALH (D), BCF (E), LIN (F) and STR (G) were determined using a 
CASA system; *Value differences compared to control samples (P< 0.05); VAP: 
Average Path Velocity, VSL: Straight-Line Velocity, VCL: Curvilinear Velocity, ALH: 
Amplitude of Lateral Head Displacement, BCF: Beat Cross Frequency, LIN: linearity 
coefficient, STR: straightness coefficient; Four fields containing among 700 and 2000 
cells were analyzed for each treatment, time and replicate (n = 3) 
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Fig. 6. Heterologous in vitro fertilization rate of frozen/thawed ram sperm treated with 
0.15 µM or 0.3 µM TrxA-FNIIx4-His6; Fertilization rate was assessed by the presence 
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of cleaved oocytes (two to eight cells) and/or the presence of two or more nuclei after 
40 h insemination; Mean values ± SEM; Different letters indicate differences between 
treatments (n = 3) 
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Table 1 
Effect of TrxA-FNIIx4-His6 (0.15 μM or 0.3 μM) on total and progressive motility of 
thawed ram sperm after 30, 60, 90 and 120 min of incubation at 37 ºC 
Treatment Incubation time 
(min) 
Total  
motility (%) 
Progressive 
motility (%) 
 
 
0.15 μM 
0 95.9 ± 0.1 36.7 ± 2.4 
30 94.7 ± 1.0 30.0 ± 4.8 
60 94.6 ± 1.2 26.2 ± 3.0 
90 92.1 ± 4.3 18.6 ± 7.8 
120 91.7 ± 0.9 16.0 ± 0.5 
 
 
0.3 μM 
0 95.8 ± 1.0 36.6 ± 3.9 
30 96.4 ± 1.9 38.0 ± 5.1 
60 94.1 ± 1.3  24.8 ± 1.6 
90 93.1 ± 1.5 21.2 ± 4.5 
120 95.2 ± 1.4 15.0 ± 6.2 
 
 
Control  
0 93.8 ± 4.9 31.3 ± 9.7 
30 95.8 ± 1.3 37.5 ± 8.7 
60 95.1± 2.7 31.8 ± 2.0 
90 92.4 ± 1.3 25.4 ± 3.5 
120 94.2 ± 1.3 26.0 ± 5.9 
Data represent means ± SEM: values for variables were determined using a CASA 
system; *Value different compared to control samples (P< 0.05); Four fields containing 
700 and 2000 cells were analyzed for each treatment, time and replicate (n = 3) 
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